Related Experiment Video
Updated: Mar 9, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Stromal Modulators of TGF-β in Cancer
Brunella Costanza1, Ijeoma Adaku Umelo2, Justine Bellier3
1Metastasis Research Laboratory, GIGA-Cancer, University of Liege, 4000 Liege, Belgium. brunellacostanza@gmail.com.
Abstract:
Transforming growth factor-β (TGF-β) is an intriguing cytokine exhibiting dual activities in malignant disease. It is an important mediator of cancer invasion, metastasis and angiogenesis, on the one hand, while it exhibits anti-tumor functions on the other hand. Elucidating the precise role of TGF-β in malignant development and progression requires a better understanding of the molecular mechanisms involved in its tumor suppressor to tumor promoter switch. One important aspect of TGF-β function is its interaction with proteins within the tumor microenvironment. Several stromal proteins have the natural ability to interact and modulate TGF-β function. Understanding the complex interplay between the TGF-β signaling network and these stromal proteins may provide greater insight into the development of novel therapeutic strategies that target the TGF-β axis. The present review highlights our present understanding of how stroma modulates TGF-β activity in human cancers.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Mesenchymal Stem Cells
Targeted Cancer Therapies
There are several types of targeted therapies against...

